Table 6.

Patients with increased CRP and normal albumin level had a better median progression free survival and median overall survival than patients with normal CRP and decreased albumin level in the patients with GPS 1 (not statistically significant)

	Patients with increased CRP and normal albumin level (n = 87)	Patients with normal CRP and decreased albumin level (n = 24)	P-value
mPFS (months)	3.433	2.533	0.489
	(95% CI 2.648-4.219)	(95% CI 0.000-5.284)
mOS (months)	8.9	8.7	0.915
	(95% CI 7.003-10.930)	(95% CI 5.779-11.621)

mPFS: median progression free survival, mOS: median overall survival, CRP: C-reactive protein